Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 26;16(8):e67795.
doi: 10.7759/cureus.67795. eCollection 2024 Aug.

Steroids in the Management of Ionotropic-Resistant Septic Shock: A Comprehensive Review of Efficacy and Outcomes

Affiliations
Review

Steroids in the Management of Ionotropic-Resistant Septic Shock: A Comprehensive Review of Efficacy and Outcomes

Nimmanagoti Nagaraju et al. Cureus. .

Abstract

Septic shock is a critical condition characterized by persistent hypotension despite adequate fluid resuscitation and the use of vasopressors, often accompanied by multi-organ dysfunction. A challenging subset, ionotropic-resistant septic shock, persists despite ionotropic support. Steroids have been explored as a treatment for septic shock due to their anti-inflammatory properties and potential to improve hemodynamic stability. This review aims to evaluate the efficacy and outcomes of steroid therapy in managing ionotropic-resistant septic shock, assessing its impact on mortality, hemodynamic parameters, and adverse effects. A comprehensive review of the current literature, including randomized controlled trials, observational studies, and clinical guidelines, was conducted. Key studies, such as the CORTICUS and ADRENAL trials, were analyzed to determine the effectiveness of steroid regimens, specifically low-dose hydrocortisone, in patients with septic shock resistant to ionotropic agents. Evidence from recent trials indicates that low-dose hydrocortisone therapy can improve hemodynamic stability and reduce mortality in patients with septic shock, including those with ionotropic resistance. However, the benefits may vary depending on the timing of intervention, patient characteristics, and the presence of contraindications. Steroid therapy is associated with potential adverse effects, including secondary infections, glucose dysregulation, and gastrointestinal issues. Steroid therapy, particularly low-dose hydrocortisone, appears to be an effective adjunctive treatment for ionotropic-resistant septic shock, offering improved shock reversal and reduced mortality. Nonetheless, careful consideration of the risks and benefits is essential, and ongoing research is needed to refine treatment protocols and optimize patient outcomes. This review provides a detailed synthesis of current evidence and offers recommendations for clinical practice and future research in the management of septic shock resistant to ionotropic agents.

Keywords: hemodynamic stability; hydrocortisone; ionotropic resistance; mortality reduction; septic shock; steroid therapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Adverse effects of steroids in septic shock.
Image Credit: Nimmanagoti Nagaraju.

Similar articles

References

    1. Septic shock: practice essentials, background, pathophysiology. August. [ Apr; 2024 ]. 2023. https://emedicine.medscape.com/article/168402-overview https://emedicine.medscape.com/article/168402-overview
    1. Chakraborty RK, Burns B. StatPearls. Treasure Island, FL: StatPearls Publishing; 2024. Systemic inflammatory response syndrome. - PubMed
    1. Morelli A, Passariello M, Singer M. Annual Update in Intensive Care and Emergency Medicine 2014. Cham, Switzerland: Springer; 2014. Inotropic support in the treatment of septic myocardial dysfunction: pathophysiological implications supporting the use of levosimendan; pp. 407–419.
    1. Fluids and early vasopressors in the management of septic shock: do we have the right answers yet? Carlos Sanchez E, Pinsky MR, Sinha S, Mishra RC, Lopa AJ, Chatterjee R. J Crit Care Med (Targu Mures) 2023;9:138–147. - PMC - PubMed
    1. Corticosteroids for septic shock. Annane D. Crit Care Med. 2001;29:0–20. - PubMed

LinkOut - more resources